Trellus Health (TRLS) Competitors

GBX 1.50
-0.25 (-14.29%)
(As of 01:27 PM ET)

TRLS vs. IQAI, FDBK, INHC, HELD, FAB, APTA, EVG, DEMG, N4P, and PYC

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), Feedback (FDBK), Induction Healthcare Group (INHC), Hellenic Dynamics (HELD), Fusion Antibodies (FAB), Aptamer Group (APTA), Evgen Pharma (EVG), Deltex Medical Group (DEMG), N4 Pharma (N4P), and Physiomics (PYC). These companies are all part of the "medical" sector.

Trellus Health vs.

Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, profitability, valuation, risk, earnings, media sentiment and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
IQ-AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Trellus Health has a net margin of 0.00% compared to IQ-AI's net margin of -85.53%. Trellus Health's return on equity of -28.43% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus HealthN/A -28.43% -18.41%
IQ-AI -85.53%-77.81%-24.00%

IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Trellus HealthN/AN/A
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%

22.1% of Trellus Health shares are held by institutional investors. Comparatively, 2.4% of IQ-AI shares are held by institutional investors. 57.7% of Trellus Health shares are held by insiders. Comparatively, 35.8% of IQ-AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£35K69.22-£6.34M-£0.03-50.00
IQ-AI£538.19K7.00N/AN/AN/A

In the previous week, IQ-AI had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for IQ-AI and 0 mentions for Trellus Health. IQ-AI's average media sentiment score of 0.28 beat Trellus Health's score of 0.00 indicating that IQ-AI is being referred to more favorably in the news media.

Company Overall Sentiment
Trellus Health Neutral
IQ-AI Neutral

Trellus Health has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.94, suggesting that its share price is 194% more volatile than the S&P 500.

Summary

Trellus Health and IQ-AI tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£2.42M£244.32M£4.95B£1.43B
Dividend YieldN/A6.26%2.83%11.96%
P/E Ratio-50.00651.41180.811,669.13
Price / Sales69.22619.922,472.01335,845.87
Price / Cash0.7641.2233.4632.93
Price / Book0.136.404.932.67
Net Income-£6.34M-£5.20M£104.54M£176.14M
7 Day Performance-22.96%1.75%1.29%1.13%
1 Month Performance-20.21%-4.75%-3.41%6.67%
1 Year Performance-78.57%-7.63%3.69%7.66%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IQAI
IQ-AI
0 of 5 stars
GBX 1.60
+6.7%
N/A-39.6%£3.55M£538,190.00-13.676Gap Up
FDBK
Feedback
0 of 5 stars
GBX 82.50
-8.3%
N/A-36.2%£11.00M£1.02M-317.3124Gap Down
INHC
Induction Healthcare Group
0 of 5 stars
GBX 12.50
flat
N/A-41.9%£11.55M£11.82M-83.3383Gap Up
HELD
Hellenic Dynamics
0 of 5 stars
GBX 2.48
+3.1%
N/AN/A£3.12MN/A0.00N/AGap Up
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.30
+0.8%
N/A-91.4%£3.15M£1.58M-36.6748
APTA
Aptamer Group
0 of 5 stars
GBX 0.68
-6.9%
N/A-95.0%£3.16M£1.03M-8.4437Gap Down
EVG
Evgen Pharma
0 of 5 stars
GBX 0.80
flat
N/A-78.1%£3.42MN/A-80.0010
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.13
flat
N/A-91.9%£2.38M£1.78M-5.7537Gap Up
N4P
N4 Pharma
0 of 5 stars
GBX 0.80
flat
N/A-62.5%£2.15M£23,524.00-120.005
PYC
Physiomics
0 of 5 stars
GBX 1.50
-3.2%
N/A-55.0%£2.03M£900,707.00-13.8310

Related Companies and Tools

This page (LON:TRLS) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners